This could help make treatments safer and more precise, leading to better outcomes for cancer patients. Scientists in Japan ...

Pancreatic cancer’s deadly resilience may be tied to extrachromosomal DNA, which allows tumor cells to rapidly adapt to ...

A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new ...

TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.

PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...

Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs) found that patients responded better to a combination of two ...

Carolyn Schutt Ibsen uses ultrasound to improve tumor targetingand tissue engineering from bioink to 3D models.

The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...

Arizona Democratic Congressman Raul Grijalva has died at 77 following complications from cancer treatment, according to his ...

Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive drug that emits alpha ...